Biomerica, Inc. (NASDAQ:BMRA) Sees Large Decline in Short Interest

Biomerica, Inc. (NASDAQ:BMRA) was the target of a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalling 364,100 shares, a decrease of 53.5% from the December 15th total of 782,800 shares. Based on an average daily volume of 894,000 shares, the short-interest ratio is currently 0.4 days.

Biomerica Stock Up 1.2 %

BMRA traded up $0.00 during midday trading on Tuesday, hitting $0.33. 3,446 shares of the company were exchanged, compared to its average volume of 244,818. The firm’s 50 day moving average price is $0.33 and its 200-day moving average price is $0.34. The firm has a market capitalization of $5.47 million, a P/E ratio of -0.88 and a beta of -1.04. Biomerica has a 1-year low of $0.24 and a 1-year high of $1.35.

Biomerica (NASDAQ:BMRA) last released its quarterly earnings results on Tuesday, October 15th. The company reported ($0.08) earnings per share (EPS) for the quarter. Biomerica had a negative return on equity of 84.62% and a negative net margin of 111.89%. The firm had revenue of $1.81 million for the quarter.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.